Metastatic Glioma
Metastatic glioma refers to the rare situation when an aggressive brain tumor called a glioma spreads beyond the brain and spinal cord to other parts of the body. While gliomas are serious tumors that often invade surrounding brain tissue, spreading outside the central nervous system is extremely uncommon.
Table of contents
- What Is a Glioma?
- When Gliomas Spread Beyond the Brain
- How Metastatic Glioma Appears
- Why Metastasis Is So Rare
- Outlook and Survival
What Is a Glioma?
A glioma is a tumor that develops from cells in the brain or spinal cord called glial cells. These cells normally support and protect nerve cells, helping them function properly[1]. When these cells grow out of control, they form a mass that can press on brain or spinal cord tissue and cause symptoms[1].
Gliomas range from slow-growing tumors to highly aggressive cancers. Healthcare providers grade them on a scale from 1 to 4 based on how fast they grow and how abnormal the cells look[4]. Grade 1 tumors grow very slowly and rarely spread, while grade 4 tumors are the most aggressive[3]. Glioblastoma, the most common type of malignant brain tumor in adults, is a grade 4 glioma[5].
- Brain
- Spinal cord
In the United States, there are 6 cases of gliomas diagnosed per 100,000 people every year[4]. These tumors can be well-defined or spread into nearby brain tissue[4]. The most common types include astrocytomas (which start in star-shaped brain cells), ependymomas, and oligodendrogliomas[4].
When Gliomas Spread Beyond the Brain
Unlike many other cancers, gliomas rarely spread to other parts of the body outside the brain and spinal cord[3]. When this does happen, doctors call it extracranial metastasis. This situation is extremely uncommon, even though gliomas can be very aggressive and invade healthy brain tissue nearby[2].
Research shows that high-grade gliomas, particularly glioblastoma, are the most likely to spread outside the central nervous system, though this remains rare[2]. Most documented cases of extracranial spread occur in patients who have already had surgery, which may allow tumor cells to escape to other areas[2].
How Metastatic Glioma Appears
When gliomas do spread beyond the brain and spinal cord, they most commonly travel to specific locations. According to medical literature, the most frequent site is within the spinal area along the neural axis (the connection between the brain and spinal cord)[2]. After that, metastases can appear in the vertebrae (bones of the spine), lungs, liver, and lymph nodes[2].
In documented cases, patients developed these distant metastases within one year after surgery for their primary glioma. One patient had spread to the cervical lymph nodes in the neck and bones, while another developed bone metastases[2]. Both patients experienced rapid decline after the metastases were discovered.
Why Metastasis Is So Rare
The exact reasons why gliomas rarely spread outside the brain and spinal cord remain unclear to researchers[2]. The blood-brain barrier, a protective layer that prevents many substances from moving between the bloodstream and brain tissue, may play a role in keeping tumor cells contained.
Experts believe that surgical disruption of the protective layers around the brain may create a pathway for tumor cells to escape into other parts of the body[2]. However, the complete mechanism behind how and why some gliomas develop the ability to metastasize remains a subject of ongoing research[2].
Outlook and Survival
The prognosis for patients with metastatic glioma is very poor. According to available medical data, patients with extracranial metastases from high-grade gliomas typically survive less than 6 months after the metastases are discovered[2]. In reported cases, both patients died within 2 months after diagnosis of their extracranial spread[2].
This devastating outcome reflects both the aggressive nature of high-grade gliomas and the challenge of treating cancer that has spread to multiple locations. The development of extracranial metastases usually occurs in patients who already have advanced disease, making treatment options limited.


